3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
4
Withdrawn
1
Unknown
1
Not yet recruiting
1
Enrolling by invitation
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
2
Plasma cell
1
Other hematologic neoplasm
1
Conditions
Multiple Myeloma
130
Neoplasms, Plasma Cell
16
Recurrence
14
Lymphoma
10
Neoplasms
9
Immunoglobulin Light-chain Amyloidosis
8
Monoclonal Gammopathy of Undetermined Significance
5
Leukemia, Plasma Cell
5
Hematologic Neoplasms
5
Waldenstrom Macroglobulinemia
3
Smoldering Multiple Myeloma
3
Paraproteinemias
3
Leukemia
3
Respiratory Aspiration
2
Ovarian Neoplasms
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Kidney Neoplasms
2
Hypoventilation
2
Gastrointestinal Neoplasms
2
Disease
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Breast Neoplasms
2
Amyloidosis
2
Venous Thromboembolism
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Taste Disorders
1
Interventions
tocilizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Cytokine Release Syndrome
×
Plasma cell
×
Clear all
NCT07609940
2026-05-27
POPLIN
Regeneron Pharmaceuticals
Phase 4
Not yet recruiting
30 enrolled